Report Cover

Global and China Anti-Hypertensive Drugs Market Insights, Forecast to 2026


Anti-Hypertensive Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Hypertensive Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Anti-Hypertensive Drugs market is segmented into
    Diuretics
    Angiotensin Converting Enzyme (ACE) Inhibitors
    Angiotensin Receptor Blockers (ARBs)
    Calcium Channel Blockers
    Beta Blockers
    Alpha Blockers
    Vasodilators
    Renin Inhibitors

Segment by Application, the Anti-Hypertensive Drugs market is segmented into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

Regional and Country-level Analysis
The Anti-Hypertensive Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Hypertensive Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Anti-Hypertensive Drugs Market Share Analysis
Anti-Hypertensive Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Hypertensive Drugs business, the date to enter into the Anti-Hypertensive Drugs market, Anti-Hypertensive Drugs product introduction, recent developments, etc.
The major vendors covered:
    Novartis
    Pfizer
    Johnson & Johnson
    Sanofi
    Lupin
    Ranbaxy Laboratories
    Merck
    AstraZeneca
    Daiichi Sankyo Company Limited
    Takeda Pharmaceutical
1 Study Coverage
    1.1 Anti-Hypertensive Drugs Product Introduction
    1.2 Market Segments
    1.3 Key Anti-Hypertensive Drugs Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Type
        1.4.2 Diuretics
        1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
        1.4.4 Angiotensin Receptor Blockers (ARBs)
        1.4.5 Calcium Channel Blockers
        1.4.6 Beta Blockers
        1.4.7 Alpha Blockers
        1.4.8 Vasodilators
        1.4.9 Renin Inhibitors
    1.5 Market by Application
        1.5.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Application
        1.5.2 Hospital Pharmacies
        1.5.3 Retail Pharmacies
        1.5.4 Online Pharmacies
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Anti-Hypertensive Drugs Market Size, Estimates and Forecasts
        2.1.1 Global Anti-Hypertensive Drugs Revenue 2015-2026
        2.1.2 Global Anti-Hypertensive Drugs Sales 2015-2026
    2.2 Global Anti-Hypertensive Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    2.3 Anti-Hypertensive Drugs Historical Market Size by Region (2015-2020)
        2.3.1 Global Anti-Hypertensive Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
        2.3.2 Global Anti-Hypertensive Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
    2.4 Anti-Hypertensive Drugs Market Estimates and Projections by Region (2021-2026)
        2.4.1 Global Anti-Hypertensive Drugs Sales Forecast by Region (2021-2026)
        2.4.2 Global Anti-Hypertensive Drugs Revenue Forecast by Region (2021-2026)

3 Global Anti-Hypertensive Drugs Competitor Landscape by Players
    3.1 Global Top Anti-Hypertensive Drugs Sales by Manufacturers
        3.1.1 Global Anti-Hypertensive Drugs Sales by Manufacturers (2015-2020)
        3.1.2 Global Anti-Hypertensive Drugs Sales Market Share by Manufacturers (2015-2020)
    3.2 Global Anti-Hypertensive Drugs Manufacturers by Revenue
        3.2.1 Global Anti-Hypertensive Drugs Revenue by Manufacturers (2015-2020)
        3.2.2 Global Anti-Hypertensive Drugs Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Anti-Hypertensive Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Anti-Hypertensive Drugs Revenue in 2019
        3.2.5 Global Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Anti-Hypertensive Drugs Price by Manufacturers
    3.4 Global Anti-Hypertensive Drugs Manufacturing Base Distribution, Product Types
        3.4.1 Anti-Hypertensive Drugs Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Anti-Hypertensive Drugs Product Type
        3.4.3 Date of International Manufacturers Enter into Anti-Hypertensive Drugs Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Anti-Hypertensive Drugs Market Size by Type (2015-2020)
        4.1.1 Global Anti-Hypertensive Drugs Sales by Type (2015-2020)
        4.1.2 Global Anti-Hypertensive Drugs Revenue by Type (2015-2020)
        4.1.3 Anti-Hypertensive Drugs Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Anti-Hypertensive Drugs Market Size Forecast by Type (2021-2026)
        4.2.1 Global Anti-Hypertensive Drugs Sales Forecast by Type (2021-2026)
        4.2.2 Global Anti-Hypertensive Drugs Revenue Forecast by Type (2021-2026)
        4.2.3 Anti-Hypertensive Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Anti-Hypertensive Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Anti-Hypertensive Drugs Market Size by Application (2015-2020)
        5.1.1 Global Anti-Hypertensive Drugs Sales by Application (2015-2020)
        5.1.2 Global Anti-Hypertensive Drugs Revenue by Application (2015-2020)
        5.1.3 Anti-Hypertensive Drugs Price by Application (2015-2020)
    5.2 Anti-Hypertensive Drugs Market Size Forecast by Application (2021-2026)
        5.2.1 Global Anti-Hypertensive Drugs Sales Forecast by Application (2021-2026)
        5.2.2 Global Anti-Hypertensive Drugs Revenue Forecast by Application (2021-2026)
        5.2.3 Global Anti-Hypertensive Drugs Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
    6.1 China Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
        6.1.1 China Anti-Hypertensive Drugs Sales YoY Growth 2015-2026
        6.1.2 China Anti-Hypertensive Drugs Revenue YoY Growth 2015-2026
        6.1.3 China Anti-Hypertensive Drugs Market Share in Global Market 2015-2026
    6.2 China Anti-Hypertensive Drugs Market Size by Players (International and Local Players)
        6.2.1 China Top Anti-Hypertensive Drugs Players by Sales (2015-2020)
        6.2.2 China Top Anti-Hypertensive Drugs Players by Revenue (2015-2020)
    6.3 China Anti-Hypertensive Drugs Historic Market Review by Type (2015-2020)
        6.3.1 China Anti-Hypertensive Drugs Sales Market Share by Type (2015-2020)
        6.3.2 China Anti-Hypertensive Drugs Revenue Market Share by Type (2015-2020)
        6.3.3 China Anti-Hypertensive Drugs Price by Type (2015-2020)
    6.4 China Anti-Hypertensive Drugs Market Estimates and Forecasts by Type (2021-2026)
        6.4.1 China Anti-Hypertensive Drugs Sales Forecast by Type (2021-2026)
        6.4.2 China Anti-Hypertensive Drugs Revenue Forecast by Type (2021-2026)
        6.4.3 China Anti-Hypertensive Drugs Price Forecast by Type (2021-2026)
    6.5 China Anti-Hypertensive Drugs Historic Market Review by Application (2015-2020)
        6.5.1 China Anti-Hypertensive Drugs Sales Market Share by Application (2015-2020)
        6.5.2 China Anti-Hypertensive Drugs Revenue Market Share by Application (2015-2020)
        6.5.3 China Anti-Hypertensive Drugs Price by Application (2015-2020)
    6.6 China Anti-Hypertensive Drugs Market Estimates and Forecasts by Application (2021-2026)
        6.6.1 China Anti-Hypertensive Drugs Sales Forecast by Application (2021-2026)
        6.6.2 China Anti-Hypertensive Drugs Revenue Forecast by Application (2021-2026)
        6.6.3 China Anti-Hypertensive Drugs Price Forecast by Application (2021-2026)

7 North America
    7.1 North America Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
    7.2 North America Anti-Hypertensive Drugs Market Facts & Figures by Country
        7.2.1 North America Anti-Hypertensive Drugs Sales by Country (2015-2020)
        7.2.2 North America Anti-Hypertensive Drugs Revenue by Country (2015-2020)
        7.2.3 U.S.
        7.2.4 Canada

8 Europe
    8.1 Europe Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
    8.2 Europe Anti-Hypertensive Drugs Market Facts & Figures by Country
        8.2.1 Europe Anti-Hypertensive Drugs Sales by Country
        8.2.2 Europe Anti-Hypertensive Drugs Revenue by Country
        8.2.3 Germany
        8.2.4 France
        8.2.5 U.K.
        8.2.6 Italy
        8.2.7 Russia

9 Asia Pacific
    9.1 Asia Pacific Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
    9.2 Asia Pacific Anti-Hypertensive Drugs Market Facts & Figures by Country
        9.2.1 Asia Pacific Anti-Hypertensive Drugs Sales by Region (2015-2020)
        9.2.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Region
        9.2.3 China
        9.2.4 Japan
        9.2.5 South Korea
        9.2.6 India
        9.2.7 Australia
        9.2.8 Taiwan
        9.2.9 Indonesia
        9.2.10 Thailand
        9.2.11 Malaysia
        9.2.12 Philippines
        9.2.13 Vietnam

10 Latin America
    10.1 Latin America Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
    10.2 Latin America Anti-Hypertensive Drugs Market Facts & Figures by Country
        10.2.1 Latin America Anti-Hypertensive Drugs Sales by Country
        10.2.2 Latin America Anti-Hypertensive Drugs Revenue by Country
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
    11.2 Middle East and Africa Anti-Hypertensive Drugs Market Facts & Figures by Country
        11.2.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Country
        11.2.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Country
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 Novartis
        12.1.1 Novartis Corporation Information
        12.1.2 Novartis Description and Business Overview
        12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
        12.1.4 Novartis Anti-Hypertensive Drugs Products Offered
        12.1.5 Novartis Recent Development
    12.2 Pfizer
        12.2.1 Pfizer Corporation Information
        12.2.2 Pfizer Description and Business Overview
        12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
        12.2.4 Pfizer Anti-Hypertensive Drugs Products Offered
        12.2.5 Pfizer Recent Development
    12.3 Johnson & Johnson
        12.3.1 Johnson & Johnson Corporation Information
        12.3.2 Johnson & Johnson Description and Business Overview
        12.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
        12.3.4 Johnson & Johnson Anti-Hypertensive Drugs Products Offered
        12.3.5 Johnson & Johnson Recent Development
    12.4 Sanofi
        12.4.1 Sanofi Corporation Information
        12.4.2 Sanofi Description and Business Overview
        12.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
        12.4.4 Sanofi Anti-Hypertensive Drugs Products Offered
        12.4.5 Sanofi Recent Development
    12.5 Lupin
        12.5.1 Lupin Corporation Information
        12.5.2 Lupin Description and Business Overview
        12.5.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
        12.5.4 Lupin Anti-Hypertensive Drugs Products Offered
        12.5.5 Lupin Recent Development
    12.6 Ranbaxy Laboratories
        12.6.1 Ranbaxy Laboratories Corporation Information
        12.6.2 Ranbaxy Laboratories Description and Business Overview
        12.6.3 Ranbaxy Laboratories Sales, Revenue and Gross Margin (2015-2020)
        12.6.4 Ranbaxy Laboratories Anti-Hypertensive Drugs Products Offered
        12.6.5 Ranbaxy Laboratories Recent Development
    12.7 Merck
        12.7.1 Merck Corporation Information
        12.7.2 Merck Description and Business Overview
        12.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
        12.7.4 Merck Anti-Hypertensive Drugs Products Offered
        12.7.5 Merck Recent Development
    12.8 AstraZeneca
        12.8.1 AstraZeneca Corporation Information
        12.8.2 AstraZeneca Description and Business Overview
        12.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
        12.8.4 AstraZeneca Anti-Hypertensive Drugs Products Offered
        12.8.5 AstraZeneca Recent Development
    12.9 Daiichi Sankyo Company Limited
        12.9.1 Daiichi Sankyo Company Limited Corporation Information
        12.9.2 Daiichi Sankyo Company Limited Description and Business Overview
        12.9.3 Daiichi Sankyo Company Limited Sales, Revenue and Gross Margin (2015-2020)
        12.9.4 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Products Offered
        12.9.5 Daiichi Sankyo Company Limited Recent Development
    12.10 Takeda Pharmaceutical
        12.10.1 Takeda Pharmaceutical Corporation Information
        12.10.2 Takeda Pharmaceutical Description and Business Overview
        12.10.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
        12.10.4 Takeda Pharmaceutical Anti-Hypertensive Drugs Products Offered
        12.10.5 Takeda Pharmaceutical Recent Development
    12.11 Novartis
        12.11.1 Novartis Corporation Information
        12.11.2 Novartis Description and Business Overview
        12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
        12.11.4 Novartis Anti-Hypertensive Drugs Products Offered
        12.11.5 Novartis Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Anti-Hypertensive Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Anti-Hypertensive Drugs Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Anti-Hypertensive Drugs Market Segments Table 2. Ranking of Global Top Anti-Hypertensive Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Anti-Hypertensive Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Diuretics Table 5. Major Manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors Table 6. Major Manufacturers of Angiotensin Receptor Blockers (ARBs) Table 7. Major Manufacturers of Calcium Channel Blockers Table 8. Major Manufacturers of Beta Blockers Table 9. Major Manufacturers of Alpha Blockers Table 10. Major Manufacturers of Vasodilators Table 11. Major Manufacturers of Renin Inhibitors Table 12. Global Anti-Hypertensive Drugs Market Size Growth Rate by Application 2020-2026 (K Units) Table 13. Global Anti-Hypertensive Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 14. Global Anti-Hypertensive Drugs Sales by Regions 2015-2020 (K Units) Table 15. Global Anti-Hypertensive Drugs Sales Market Share by Regions (2015-2020) Table 16. Global Anti-Hypertensive Drugs Revenue by Regions 2015-2020 (US$ Million) Table 17. Global Anti-Hypertensive Drugs Sales Forecast by Region (2021-2026) (K Units) Table 18. Global Anti-Hypertensive Drugs Sales by Manufacturers (2015-2020) (K Units) Table 19. Global Anti-Hypertensive Drugs Sales Share by Manufacturers (2015-2020) Table 20. Global Anti-Hypertensive Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 21. Global Anti-Hypertensive Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Hypertensive Drugs as of 2019) Table 22. Anti-Hypertensive Drugs Revenue by Manufacturers (2015-2020) (US$ Million) Table 23. Anti-Hypertensive Drugs Revenue Share by Manufacturers (2015-2020) Table 24. Key Manufacturers Anti-Hypertensive Drugs Price (2015-2020) (USD/Pcs) Table 25. Anti-Hypertensive Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 26. Manufacturers Anti-Hypertensive Drugs Product Type Table 27. Date of International Manufacturers Enter into Anti-Hypertensive Drugs Market Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans Table 29. Global Anti-Hypertensive Drugs Sales by Type (2015-2020) (K Units) Table 30. Global Anti-Hypertensive Drugs Sales Share by Type (2015-2020) Table 31. Global Anti-Hypertensive Drugs Revenue by Type (2015-2020) (US$ Million) Table 32. Global Anti-Hypertensive Drugs Revenue Share by Type (2015-2020) Table 33. Anti-Hypertensive Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs) Table 34. Global Anti-Hypertensive Drugs Sales Share by Type (2021-2026) Table 35. Global Anti-Hypertensive Drugs Sales by Application (2015-2020) (K Units) Table 36. Global Anti-Hypertensive Drugs Sales Share by Application (2015-2020) Table 37. Global Anti-Hypertensive Drugs Sales Share by Application (2021-2026) Table 38. Global Anti-Hypertensive Drugs Sales Market Share Forecast by Application (2021-2026) Table 39. Global Anti-Hypertensive Drugs Revenue by Application (2015-2020) (US$ Million) Table 40. Global Anti-Hypertensive Drugs Revenue Market Share Forecast by Application (2021-2026) Table 41. China Anti-Hypertensive Drugs Sales (K Units) of Key Companies (2015-2020) Table 42. China Anti-Hypertensive Drugs Sales Share by Company (2015-2020) Table 43. China Anti-Hypertensive Drugs Revenue (US$ Million) by Company (2015-2020) Table 44. China Anti-Hypertensive Drugs Sales (K Units) by Type (2015-2020) Table 45. China Anti-Hypertensive Drugs Sales Share by Type (2015-2020) Table 46. China Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Type (2015-2020) Table 47. China Anti-Hypertensive Drugs Price (K Units) by Type (2015-2020) Table 48. China Anti-Hypertensive Drugs Sales (K Units) by Type (2021-2026) Table 49. China Anti-Hypertensive Drugs Sales Share by Type (2021-2026) Table 50. China Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Type (2021-2026) Table 51. China Anti-Hypertensive Drugs Revenue Share by Type (2021-2026) Table 52. China Anti-Hypertensive Drugs Price (K Units) by Type (2021-2026) Table 53. China Anti-Hypertensive Drugs Sales (K Units) by Application (2015-2020) Table 54. China Anti-Hypertensive Drugs Sales Share by Application (2015-2020) Table 55. China Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Application (2015-2020) Table 56. China Anti-Hypertensive Drugs Sales (K Units) by Application (2021-2026) Table 57. China Anti-Hypertensive Drugs Sales Share by Application (2021-2026) Table 58. China Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Application (2021-2026) Table 59. China Anti-Hypertensive Drugs Revenue Share by Application (2021-2026) Table 60. North America Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units) Table 61. North America Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020) Table 62. North America Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million) Table 63. North America Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020) Table 64. Europe Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units) Table 65. Europe Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020) Table 66. Europe Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million) Table 67. Europe Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020) Table 68. Asia Pacific Anti-Hypertensive Drugs Sales by Region (2015-2020) (K Units) Table 69. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Region (2015-2020) Table 70. Asia Pacific Anti-Hypertensive Drugs Revenue by Region (2015-2020) (US$ Million) Table 71. Asia Pacific Anti-Hypertensive Drugs Revenue Market Share by Region (2015-2020) Table 72. Latin America Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units) Table 73. Latin America Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020) Table 74. Latin Americaa Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million) Table 75. Latin America Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020) Table 76. Middle East and Africa Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units) Table 77. Middle East and Africa Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020) Table 78. Middle East and Africa Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million) Table 79. Middle East and Africa Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020) Table 80. Novartis Corporation Information Table 81. Novartis Description and Business Overview Table 82. Novartis Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 83. Novartis Anti-Hypertensive Drugs Product Table 84. Novartis Recent Development Table 85. Pfizer Corporation Information Table 86. Pfizer Description and Business Overview Table 87. Pfizer Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 88. Pfizer Product Table 89. Pfizer Recent Development Table 90. Johnson & Johnson Corporation Information Table 91. Johnson & Johnson Description and Business Overview Table 92. Johnson & Johnson Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 93. Johnson & Johnson Product Table 94. Johnson & Johnson Recent Development Table 95. Sanofi Corporation Information Table 96. Sanofi Description and Business Overview Table 97. Sanofi Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 98. Sanofi Product Table 99. Sanofi Recent Development Table 100. Lupin Corporation Information Table 101. Lupin Description and Business Overview Table 102. Lupin Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 103. Lupin Product Table 104. Lupin Recent Development Table 105. Ranbaxy Laboratories Corporation Information Table 106. Ranbaxy Laboratories Description and Business Overview Table 107. Ranbaxy Laboratories Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 108. Ranbaxy Laboratories Product Table 109. Ranbaxy Laboratories Recent Development Table 110. Merck Corporation Information Table 111. Merck Description and Business Overview Table 112. Merck Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 113. Merck Product Table 114. Merck Recent Development Table 115. AstraZeneca Corporation Information Table 116. AstraZeneca Description and Business Overview Table 117. AstraZeneca Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 118. AstraZeneca Product Table 119. AstraZeneca Recent Development Table 120. Daiichi Sankyo Company Limited Corporation Information Table 121. Daiichi Sankyo Company Limited Description and Business Overview Table 122. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 123. Daiichi Sankyo Company Limited Product Table 124. Daiichi Sankyo Company Limited Recent Development Table 125. Takeda Pharmaceutical Corporation Information Table 126. Takeda Pharmaceutical Description and Business Overview Table 127. Takeda Pharmaceutical Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 128. Takeda Pharmaceutical Product Table 129. Takeda Pharmaceutical Recent Development Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 131. Key Challenges Table 132. Market Risks Table 133. Main Points Interviewed from Key Anti-Hypertensive Drugs Players Table 134. Anti-Hypertensive Drugs Customers List Table 135. Anti-Hypertensive Drugs Distributors List Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Anti-Hypertensive Drugs Product Picture Figure 2. Global Anti-Hypertensive Drugs Sales Market Share by Type in 2020 & 2026 Figure 3. Diuretics Product Picture Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Product Picture Figure 5. Angiotensin Receptor Blockers (ARBs) Product Picture Figure 6. Calcium Channel Blockers Product Picture Figure 7. Beta Blockers Product Picture Figure 8. Alpha Blockers Product Picture Figure 9. Vasodilators Product Picture Figure 10. Renin Inhibitors Product Picture Figure 11. Global Anti-Hypertensive Drugs Sales Market Share by Application in 2020 & 2026 Figure 12. Hospital Pharmacies Figure 13. Retail Pharmacies Figure 14. Online Pharmacies Figure 15. Anti-Hypertensive Drugs Report Years Considered Figure 16. Global Anti-Hypertensive Drugs Market Size 2015-2026 (US$ Million) Figure 17. Global Anti-Hypertensive Drugs Sales 2015-2026 (K Units) Figure 18. Global Anti-Hypertensive Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 19. Global Anti-Hypertensive Drugs Sales Market Share by Region (2015-2020) Figure 20. Global Anti-Hypertensive Drugs Sales Market Share by Region in 2019 Figure 21. Global Anti-Hypertensive Drugs Revenue Market Share by Region (2015-2020) Figure 22. Global Anti-Hypertensive Drugs Revenue Market Share by Region in 2019 Figure 23. Global Anti-Hypertensive Drugs Sales Share by Manufacturer in 2019 Figure 24. The Top 10 and 5 Players Market Share by Anti-Hypertensive Drugs Revenue in 2019 Figure 25. Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 26. Global Anti-Hypertensive Drugs Sales Market Share by Type (2015-2020) Figure 27. Global Anti-Hypertensive Drugs Sales Market Share by Type in 2019 Figure 28. Global Anti-Hypertensive Drugs Revenue Market Share by Type (2015-2020) Figure 29. Global Anti-Hypertensive Drugs Revenue Market Share by Type in 2019 Figure 30. Global Anti-Hypertensive Drugs Market Share by Price Range (2015-2020) Figure 31. Global Anti-Hypertensive Drugs Sales Market Share by Application (2015-2020) Figure 32. Global Anti-Hypertensive Drugs Sales Market Share by Application in 2019 Figure 33. Global Anti-Hypertensive Drugs Revenue Market Share by Application (2015-2020) Figure 34. Global Anti-Hypertensive Drugs Revenue Market Share by Application in 2019 Figure 35. China Anti-Hypertensive Drugs Sales Growth Rate 2015-2026 (K Units) Figure 36. China Anti-Hypertensive Drugs Revenue Growth Rate 2015-2026 (US$ Million) Figure 37. China Anti-Hypertensive Drugs Market Share in Global Market 2015-2026 Figure 38. China 5 and 10 Largest Anti-Hypertensive Drugs Players Market Share by Revenue in Anti-Hypertensive Drugs in 2019 Figure 39. China Anti-Hypertensive Drugs Revenue Share by Type (2015-2020) Figure 40. China Anti-Hypertensive Drugs Revenue Growth Rate by Type in 2015 & 2019 Figure 41. China Anti-Hypertensive Drugs Revenue Share by Application (2015-2020) Figure 42. China Anti-Hypertensive Drugs Revenue Growth Rate by Application in 2015 & 2019 Figure 43. North America Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units) Figure 44. North America Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 45. North America Anti-Hypertensive Drugs Sales Market Share by Country in 2019 Figure 46. North America Anti-Hypertensive Drugs Revenue Market Share by Country in 2019 Figure 47. U.S. Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 48. U.S. Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Canada Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 50. Canada Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Europe Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units) Figure 52. Europe Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 53. Europe Anti-Hypertensive Drugs Sales Market Share by Country in 2019 Figure 54. Europe Anti-Hypertensive Drugs Revenue Market Share by Country in 2019 Figure 55. Germany Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 56. Germany Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. France Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 58. France Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. U.K. Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 60. U.K. Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Italy Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 62. Italy Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Russia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 64. Russia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Asia Pacific Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units) Figure 66. Asia Pacific Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 67. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Region in 2019 Figure 68. Asia Pacific Anti-Hypertensive Drugs Revenue Market Share by Region in 2019 Figure 69. China Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 70. China Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Japan Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 72. Japan Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. South Korea Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. South Korea Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. India Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. India Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Australia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 78. Australia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Taiwan Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 80. Taiwan Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Indonesia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 82. Indonesia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Thailand Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 84. Thailand Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Malaysia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 86. Malaysia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 87. Philippines Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 88. Philippines Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 89. Vietnam Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 90. Vietnam Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Latin America Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units) Figure 92. Latin America Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 93. Latin America Anti-Hypertensive Drugs Sales Market Share by Country in 2019 Figure 94. Latin America Anti-Hypertensive Drugs Revenue Market Share by Country in 2019 Figure 95. Mexico Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 96. Mexico Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 97. Brazil Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 98. Brazil Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 99. Argentina Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 100. Argentina Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Middle East and Africa Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units) Figure 102. Middle East and Africa Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 103. Middle East and Africa Anti-Hypertensive Drugs Sales Market Share by Country in 2019 Figure 104. Middle East and Africa Anti-Hypertensive Drugs Revenue Market Share by Country in 2019 Figure 105. Turkey Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 106. Turkey Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. Saudi Arabia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 108. Saudi Arabia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 109. U.A.E Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units) Figure 110. U.A.E Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 111. Porter's Five Forces Analysis Figure 112. Anti-Hypertensive Drugs Value Chain Figure 113. Channels of Distribution Figure 114. Distributors Profiles Figure 115. Bottom-up and Top-down Approaches for This Report Figure 116. Data Triangulation Figure 117. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global and United States Boric Acid Compound Market Insights, Forecast to 2026

Boric Acid Compound market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Boric Acid Compound market will be able to gain the upper hand as they use the report as a ...

Global and Japan Bone Densitometers Devices Market Insights, Forecast to 2026

Bone Densitometers Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bone Densitometers Devices market will be able to gain the upper hand as they use th...

Global and Japan Blu-ray Media Market Size, Status and Forecast 2020-2026

Global Blu-ray Media Scope and Market Size Blu-ray Media market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Blu-ray Media market will be able to gain the upper hand as they use the report as ...

Global and China Blu-ray Devices Market Insights, Forecast to 2026

Blu-ray Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Blu-ray Devices market will be able to gain the upper hand as they use the report as a powerful...

Global and United States Blood Donor Armchair Market Insights, Forecast to 2026

Blood Donor Armchair market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Blood Donor Armchair market will be able to gain the upper hand as they use the report as ...

Publisher: QY Research
Chat with us